• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子激动剂结合的德尔塔阿片受体-G 复合物的冷冻电镜结构使偏性化合物的发现成为可能。

Cryo-EM structure of small-molecule agonist bound delta opioid receptor-G complex enables discovery of biased compound.

机构信息

Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Department of Otolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

出版信息

Nat Commun. 2024 Sep 27;15(1):8284. doi: 10.1038/s41467-024-52601-1.

DOI:10.1038/s41467-024-52601-1
PMID:39333070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11437176/
Abstract

Delta opioid receptor (δOR) plays a pivotal role in modulating human sensation and emotion. It is an attractive target for drug discovery since, unlike Mu opioid receptor, it is associated with low risk of drug dependence. Despite its potential applications, the pharmacological properties of δOR, including the mechanisms of activation by small-molecule agonists and the complex signaling pathways it engages, as well as their relation to the potential side effects, remain poorly understood. In this study, we use cryo-electron microscopy (cryo-EM) to determine the structure of the δOR-G complex when bound to a small-molecule agonist (ADL5859). Moreover, we design a series of probes to examine the key receptor-ligand interaction site and identify a region involved in signaling bias. Using ADL06 as a chemical tool, we elucidate the relationship between the β-arrestin pathway of the δOR and its biological functions, such as analgesic tolerance and convulsion activities. Notably, we discover that the β-arrestin recruitment of δOR might be linked to reduced gastrointestinal motility. These insights enhance our understanding of δOR's structure, signaling pathways, and biological functions, paving the way for the structure-based drug discovery.

摘要

德尔塔阿片受体(δOR)在调节人类感觉和情绪方面起着关键作用。它是药物发现的一个有吸引力的靶点,因为与μ阿片受体不同,它与药物依赖的低风险相关。尽管具有潜在的应用前景,但 δOR 的药理学特性,包括小分子激动剂激活的机制和它所涉及的复杂信号通路,以及它们与潜在副作用的关系,仍然知之甚少。在这项研究中,我们使用冷冻电子显微镜(cryo-EM)来确定 δOR-G 复合物与小分子激动剂(ADL5859)结合时的结构。此外,我们设计了一系列探针来检查关键的受体-配体相互作用位点,并确定一个参与信号偏向的区域。使用 ADL06 作为化学工具,我们阐明了 δOR 的β-arrestin 途径与其生物学功能(如镇痛耐受和惊厥活性)之间的关系。值得注意的是,我们发现 δOR 的β-arrestin 募集可能与胃肠道蠕动减少有关。这些见解增强了我们对 δOR 结构、信号通路和生物学功能的理解,为基于结构的药物发现铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/0c7286763292/41467_2024_52601_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/2e1cb209f596/41467_2024_52601_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/597db5c82f36/41467_2024_52601_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/6902288ba52e/41467_2024_52601_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/f77adcba609f/41467_2024_52601_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/0c7286763292/41467_2024_52601_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/2e1cb209f596/41467_2024_52601_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/597db5c82f36/41467_2024_52601_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/6902288ba52e/41467_2024_52601_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/f77adcba609f/41467_2024_52601_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0174/11437176/0c7286763292/41467_2024_52601_Fig5_HTML.jpg

相似文献

1
Cryo-EM structure of small-molecule agonist bound delta opioid receptor-G complex enables discovery of biased compound.小分子激动剂结合的德尔塔阿片受体-G 复合物的冷冻电镜结构使偏性化合物的发现成为可能。
Nat Commun. 2024 Sep 27;15(1):8284. doi: 10.1038/s41467-024-52601-1.
2
Structure-guided design of partial agonists at an opioid receptor.阿片受体部分激动剂的结构导向设计。
Nat Commun. 2025 Mar 13;16(1):2518. doi: 10.1038/s41467-025-57734-5.
3
Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.作为一种潜在的靶向μ-δ阿片受体异聚体配体的埃卢多啉的分子特征
Biochem Pharmacol. 2014 Dec 1;92(3):448-56. doi: 10.1016/j.bcp.2014.09.015. Epub 2014 Sep 28.
4
Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities.鉴定具有潜在负变构调节剂能力的新型 δ 阿片受体激动剂化学型。
Molecules. 2021 Nov 29;26(23):7236. doi: 10.3390/molecules26237236.
5
Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel Opioid Receptor-Selective Agonist Chemotype.鉴定 1,3,8-三氮杂螺[4.5]癸烷-2,4-二酮衍生物为新型阿片受体选择性激动剂化学型。
J Pharmacol Exp Ther. 2024 May 21;389(3):301-309. doi: 10.1124/jpet.123.001735.
6
The Meta-Position of Phe in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors.苯丙氨酸在亮氨酸脑啡肽中的介位调控 δ 和 μ 阿片受体的效力、选择性、功能活性和信号偏向性。
Molecules. 2019 Dec 12;24(24):4542. doi: 10.3390/molecules24244542.
7
Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.鉴定具有镇痛活性的 μ-δ 阿片受体异源二聚体偏向激动剂。
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12072-7. doi: 10.1073/pnas.1222044110. Epub 2013 Jul 1.
8
Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures.脑内受体表达和信号转导特性,以及导致 δ 阿片受体激动剂诱导癫痫发作的结构配体基序。
Neuropharmacology. 2023 Jul 1;232:109526. doi: 10.1016/j.neuropharm.2023.109526. Epub 2023 Mar 31.
9
Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization.Src在δ-阿片受体脱敏和内化的配体特异性调节中的作用。
J Neurochem. 2009 Jan;108(1):102-14. doi: 10.1111/j.1471-4159.2008.05740.x. Epub 2008 Nov 10.
10
In Vitro Analyses of Spinach-Derived Opioid Peptides, Rubiscolins: Receptor Selectivity and Intracellular Activities through G Protein- and β-Arrestin-Mediated Pathways.菠菜来源阿片样肽(Rubiscolins)的体外分析:通过 G 蛋白和β-arrestin 介导的途径的受体选择性和细胞内活性。
Molecules. 2021 Oct 8;26(19):6079. doi: 10.3390/molecules26196079.

引用本文的文献

1
Steric control of signaling bias in the immunometabolic receptor GPR84.免疫代谢受体GPR84中信号偏向的空间控制
bioRxiv. 2025 Aug 2:2025.07.30.667614. doi: 10.1101/2025.07.30.667614.
2
Investigation of the Binding Characteristics of Agonists and Various Antagonists Targeting Histamine 1 Receptor.组胺1受体激动剂和各类拮抗剂结合特性的研究
Pharm Res. 2025 Aug;42(8):1315-1329. doi: 10.1007/s11095-025-03899-z. Epub 2025 Aug 4.
3
Pharmacology and Toxicology of Opioids-Recent Advances and New Perspectives.阿片类药物的药理学与毒理学——最新进展与新视角

本文引用的文献

1
Specific pharmacological and G protein responses of some native GPCRs in neurons.一些神经元中天然 G 蛋白偶联受体的特定药理学和 G 蛋白反应。
Nat Commun. 2024 Mar 5;15(1):1990. doi: 10.1038/s41467-024-46177-z.
2
A minority of final stacks yields superior amplitude in single-particle cryo-EM.少数最终堆叠可在单颗粒 cryo-EM 中产生更高的幅度。
Nat Commun. 2023 Dec 10;14(1):7822. doi: 10.1038/s41467-023-43555-x.
3
A Novel Bifunctional μOR Agonist and σR Antagonist with Potent Analgesic Responses and Reduced Adverse Effects.一种新型双功能 μOR 激动剂和 σR 拮抗剂,具有强大的镇痛反应和减少不良反应。
Pharmaceuticals (Basel). 2025 Jul 18;18(7):1055. doi: 10.3390/ph18071055.
4
Fentanyl-Antibody Interaction as a Novel Strategy against Opiates and Opioids Abuse.芬太尼-抗体相互作用作为一种对抗阿片类药物滥用的新策略。
J Med Chem. 2025 Apr 24;68(8):7866-7888. doi: 10.1021/acs.jmedchem.4c02860. Epub 2025 Apr 3.
5
Structure-guided design of partial agonists at an opioid receptor.阿片受体部分激动剂的结构导向设计。
Nat Commun. 2025 Mar 13;16(1):2518. doi: 10.1038/s41467-025-57734-5.
J Med Chem. 2023 Dec 14;66(23):16257-16275. doi: 10.1021/acs.jmedchem.3c01637. Epub 2023 Nov 28.
4
Ligand recognition and G-protein coupling of trace amine receptor TAAR1.痕量胺受体 TAAR1 的配体识别和 G 蛋白偶联。
Nature. 2023 Dec;624(7992):672-681. doi: 10.1038/s41586-023-06804-z. Epub 2023 Nov 7.
5
Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures.脑内受体表达和信号转导特性,以及导致 δ 阿片受体激动剂诱导癫痫发作的结构配体基序。
Neuropharmacology. 2023 Jul 1;232:109526. doi: 10.1016/j.neuropharm.2023.109526. Epub 2023 Mar 31.
6
Duloxetine and Amitriptyline Reduce Neuropathic Pain by Inhibiting Primary Sensory Input to Spinal Dorsal Horn Neurons via α1- and α2-Adrenergic Receptors.度洛西汀和阿米替林通过α1和α2肾上腺素能受体抑制初级感觉传入脊髓背角神经元,从而减轻神经性疼痛。
ACS Chem Neurosci. 2023 Apr 5;14(7):1261-1277. doi: 10.1021/acschemneuro.2c00780. Epub 2023 Mar 17.
7
Structures of the entire human opioid receptor family.人类阿片受体家族的结构。
Cell. 2023 Jan 19;186(2):413-427.e17. doi: 10.1016/j.cell.2022.12.026. Epub 2023 Jan 12.
8
Structure-based design of bitopic ligands for the µ-opioid receptor.基于结构的μ-阿片受体双位点配体设计。
Nature. 2023 Jan;613(7945):767-774. doi: 10.1038/s41586-022-05588-y. Epub 2022 Nov 30.
9
Insights into distinct signaling profiles of the µOR activated by diverse agonists.深入了解不同激动剂激活的 µOR 产生的独特信号转导谱。
Nat Chem Biol. 2023 Apr;19(4):423-430. doi: 10.1038/s41589-022-01208-y. Epub 2022 Nov 21.
10
Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.吗啡和芬太尼与人 μ 阿片受体的分子识别。
Cell. 2022 Nov 10;185(23):4361-4375.e19. doi: 10.1016/j.cell.2022.09.041.